Bayesian Capital Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Buy |
+6,868
| New | +$253K | 0.04% | 419 |
|
|
2025
Q1 | – | Sell |
-10,811
| Closed | -$502K | – | 970 |
|
|
2024
Q4 | $502K | Buy |
+10,811
| New | +$502K | 0.06% | 369 |
|
|
2024
Q3 | – | Sell |
-20,846
| Closed | -$1.03M | – | 1044 |
|
|
2024
Q2 | $1.03M | Buy |
20,846
+6,300
| +43% | +$310K | 0.12% | 229 |
|
|
2024
Q1 | $499K | Buy |
14,546
+4,352
| +43% | +$149K | 0.05% | 437 |
|
|
2023
Q4 | $376K | Buy |
+10,194
| New | +$376K | 0.04% | 448 |
|
|
2023
Q1 | – | Sell |
-19,975
| Closed | -$476K | – | 1095 |
|
|
2022
Q4 | $476K | Buy |
+19,975
| New | +$476K | 0.07% | 370 |
|
|
2022
Q2 | – | Sell |
-8,800
| Closed | -$435K | – | 1085 |
|
|
2022
Q1 | $435K | Buy |
+8,800
| New | +$435K | 0.06% | 411 |
|